We are international
Donate
TEXT SIZE   
   back

International Myeloma Working Group (IMWG) Guidelines for Serum Free Light Chain Analysis in Multiple Myeloma and Related Disorders
07.09.10

Be the first to comment

 related articles
Management of Treatment-Emergent Peripheral Neuropathy
Allogeneic Stem Cell Transplant
Molecular (Genetic) Classification
Serum Free Light Chain Analysis
Response Criteria
Prevention of Blood Clots (Thromboembolic Events)
Vertebral Augmentation
Treatment of Older Patients/Ineligible for Transplant
Diagnosis and Diagnostic Work-up of Myeloma
Requirements for a Myeloma Specialty Center (Facilities and Services)
Imaging Techniques for Diagnosis and Monitoring
Bisphosphonate Therapy (Zometa and Aredia)


You might also be interested in:

Management of Treatment-Emergent Peripheral Neuropathy
Strategies for managing PN include early and regular monitoring, dose modification, and treatment discontinuation.

Allogeneic Stem Cell Transplant

Molecular (Genetic) Classification

Serum Free Light Chain Analysis

Response Criteria

Prevention of Blood Clots (Thromboembolic Events)

Vertebral Augmentation

Treatment of Older Patients/Ineligible for Transplant

Diagnosis and Diagnostic Work-up of Myeloma

Requirements for a Myeloma Specialty Center (Facilities and Services)

Imaging Techniques for Diagnosis and Monitoring

Bisphosphonate Therapy (Zometa and Aredia)